
The increasing value of Medica worldwide
A statement by Jochen Franke, CEO of Philips Healthcare Germany, Austria and Switzerlandand, Head of the Advisory Council at MEDICA 2010.
A statement by Jochen Franke, CEO of Philips Healthcare Germany, Austria and Switzerlandand, Head of the Advisory Council at MEDICA 2010.
In a European Hospital interview Professor Herman Requardt, Head of Corporate Technology and CEO of Siemens Healthcare Sector, offered his views on current and future healthcare manufacturing needs as well as the market challenge arising from the dynamic economic ascent of other nations.
The Italian firm Internazionale Medico Scientifica (IMS) produces highly innovative mammography units under the brand name Giotto. More than 3,500 Giotto systems are now in use in 38 countries, mostly in Europe, America, China and the Far East. Reason enough for European Hospital to visit IMS in Pontecchio Marconi, Bologna.
Siemens Automation and Drives (A&D) division developed and supplied monitors exclusively for Siemens Medical until, about 20 years ago, the customer base expanded and A&D ultimately supplied almost all major medical technology firms with monitors for integration into their systems. In 2007, Siemens decided to focus on its core business and sell off its medical monitors division.
In Switzerland, they say, the clocks tick a little slower than elsewhere in the world. Not at Schiller AG in Baar, however: The company remains forever ahead of the times. Since 1971, physicist Alfred E Schiller, the company’s founder and managing director, has successfully shown competitors in the tough intensive and emergency care market what innovative progress really means.
Looking ahead to MEDICA 2010 (17 to 20 November) the signs are good. The high number of registrations is a sign of optimism in the medical technology industry and the number of exhibitors has already seen a significant increase in comparison to last year. With six months left to go until the fair begins, some 115,000 square metres of exhibition space had already been booked.
The well established, universal health care structures of EU countries with most specialty practices located within hospitals has led to a more advanced electronic patient record environment. Globally, 2/3 of Health Care Professionals have already implemented Electronic Patient Record systems but the US lags with less than half.
GE and Intel Corporation have announced the entry into a definitive agreement to form a 50/50 joint venture to create a new healthcare company focused on telehealth and independent living. The new company will be formed by combining assets of GE Healthcare’s Home Health division and Intel’s Digital Health Group, and will be owned equally by GE and Intel.
Based on its recent analysis of the medical imaging market, Frost & Sullivan recognises Carestream Health, Inc., with the 2010 North American Frost & Sullivan Company of the Year Award. By implementing successful product and business strategies across the two pillars of its medical imaging business - digital/computed radiography (DR/CR) and imaging informatics - Carestream Health has…
The World of Health IT Conference & Exhibition (WoHIT) -- the first joint eHealth conference of the European Commission and the Healthcare Information and Management Systems Society (HIMSS Europe) --- was held in Barcelona this March, creating Europe’s largest gathering of Information and Communication Technologies (ICTs) stakeholder groups as well as end-users, hospital CEOs, practitioners and…
GE Healthcare has now announced the sales launch of the Optima CT660*. The new system is a modular, all-round computer tomography (CT) product for all applications that uses extremely low doses of radiation, is economical with electricity and is extremely cost-effective. It is especially suitable for use in clinics and general hospitals. GE Healthcare is unveiling the groundbreaking 64-slice CT…
Last January Dr Maurizio Pupi became the International Business Manager of Vanguard Healthcare – the UK supplier of mobile healthcare facilities – which intends to spread its already very established and necessary services beyond the United Kingdom.
European healthcare providers could benefit from savings of over €3.8 billion a year by 2014 as patents expire on leading pharmaceutical products and the market opens up to generics competition, according to latest research from independent market analyst Datamonitor (www.datamonitor.com).
iSOFT Group Limited, Australia's largest listed health information technology company, today announced that St Jansdal Hospital in the Netherlands extended its contract for iSOFT’s Lorenzo solution for a further three years, in a deal worth €4.5 million.
From 1 April 2010, the Olympus Group will be pooling its expertise in the field of minimally invasive diagnostics and therapy under a common “Olympus Surgical Technologies Europe” umbrella. To this end, Olympus Winter & Ibe GmbH, Celon AG and Olympus Medical Products Czech SPOL. S.R.O. will be joining forces to accomplish a shared presence under a new, single brand.
The eHospital Census is a comprehensive historical record of healthcare IT installations at the functional level. Regarding hospitals in 12 European countries and 44 software applications (like Radiology Informations System or PACS) the eHospital Census contains descriptions of the installed base including availability, scope, market share, age profile, and life span of installations. The…
There are huge differences in the quality of medical IT systems, particularly in some East European countries. However, recent political and economic changes in that region have been accompanied by improved quality standards. In Poland, Hungary, Romania, Bosnia, Croatia, Greece, the Czech Republic, Russia, Portugal, Ireland, Turkey and Switzerland, the privately funded group Euromedic…
With a network of distributors covering 100 countries, a loyal base of customers driving double-digit growth and a full line of ultrasound scanners touching every clinical application, from advanced cardiology to routine examinations, Sonoscape reports that it is solidly ranked among the top companies for medical imaging in Europe.
Combining a dedicated R&D team and with acquisitions of key companies, Landwind Medical is aiming to provide products and services for direct patient care. Managing Vice President Wang Guozhong shares a passion for medical imaging with the company’s founder and confirms that ultrasound and radiology will remain a core focus as the firm continues to expand internationally.
Molecular imaging, a new science that emerged from molecular biology, is unlike traditional imaging. Whilst the latter can, for example, show the differences in proton density or water content on MRI, molecular imaging uses biomarkers (probes) that interact selectively with molecules within an area and then generate the image according to fine molecular alterations occurring inside (e.g. within a…
During Medica 2009, Daniela Zimmermann met with Ting Yang, Vice President of International Marketing for the Chinese company, Mindray Medical International Co. Ltd. Their discussion ranged from the company’s products to its present and future position in Europe.
In the Q110 update of “China Pharmaceuticals and Healthcare Report” from Research and Markets, China has maintained its fourth place in the Pharmaceutical Business Environment Ratings matrix for the 15 key markets in the Asia Pacific region. Globally, the country places 18th out of the 71 countries surveyed worldwide, indicating its vast potential. Key attractions are its sheer size and the…
The 'omics' revolution of the last decade has ensured that the field of biomarker research will test the frontiers of biomedical research in the coming years. Biomarkers have a multitude of applications such as early disease detection, identifying potential drug targets, predicting patient response to medication and accelerating clinical trials. Along with its role in making personalised medicine…
The Council of Europe member states will launch an inquiry in January 2010 on the influence of the pharmaceutical companies on the global swine flu campaign, focusing especially on extent of the pharma's industry's influence on WHO. The Health Committee of the EU Parliament has unanimously passed a resolution calling for the inquiry.
Organised by the Syndicat des Biologistes (SDB) the annual meeting in November, under the auspices of the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC), the European Federation of Clinical Chemistry and Laboratory Medicine (EFCC) and the French Society of Clinical Biology (SFBC), the Journees Internationales de Biologie (JIB) aims to meet the needs of the 10,700…